Amgen Inc. (formerly Applied Molecular Genetics Inc.) is a multinational biopharmaceutical company. The Company's largest selling product lines are Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Company Growth (employees)
Type
Public
HQ
Thousand Oaks, US
Founded
1980
Size (employees)
19,200 (est)
Website
amgen.com
Amgen was founded in 1980 and is headquartered in Thousand Oaks, US

Key People at Amgen

Robert Bradway

Robert Bradway

Chairman and Chief Executive Officer
Suzanne Blaug

Suzanne Blaug

SVP, Global Marketing and Commercial Development

Amgen Office Locations

Amgen has offices in Thousand Oaks, San Francisco, South San Francisco, Bucharest and in 58 other locations
Thousand Oaks, US (HQ)
One Amgen Center Drive
Show all (62)

Amgen Data and Metrics

Amgen Financial Metrics

Amgen's revenue was reported to be $23 b in FY, 2016 which is a 6% increase from the previous period.
USD

Revenue (FY, 2016)

23 b

Revenue growth (FY, 2015 - FY, 2016), %

6%

Gross profit (FY, 2016)

18.8 b

Gross profit margin (FY, 2016), %

82%

Net income (FY, 2016)

7.7 b

EBIT (FY, 2016)

9.8 b

Market capitalization (18-Aug-2017)

123.5 b

Cash (31-Dec-2016)

3.2 b

EV

154.8 b
Amgen's current market capitalization is $123.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

18.7 b20.1 b21.7 b23 b

Revenue growth, %

7%8%6%

Cost of goods sold

3.3 b4.4 b4.2 b4.2 b

Gross profit

15.3 b15.6 b17.4 b18.8 b

Gross profit Margin, %

82%78%80%82%

Operating expense total

12.8 b13.9 b13.2 b13.2 b

EBIT

5.9 b6.2 b8.5 b9.8 b

EBIT margin, %

31%31%39%43%

Interest expense

1 b1.1 b1.1 b1.3 b

Pre tax profit

5.3 b5.6 b8 b9.2 b

Income tax expense

184 m427 m1 b1.4 b

Net Income

5.1 b5.2 b6.9 b7.7 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.8 b3.7 b4.1 b3.2 b

Accounts Receivable

2.7 b2.5 b3 b3.2 b

Inventories

3 b2.6 b2.4 b2.7 b

Current Assets

27.4 b34.7 b38.5 b46 b

PP&E

5.3 b5.2 b4.9 b5 b

Goodwill

15 b14.8 b14.8 b14.8 b

Total Assets

66.1 b69 b71.6 b77.6 b

Accounts Payable

787 m1.2 b965 m917 m

Total Debt

32.1 b30.7 b31.6 b34.6 b

Current Liabilities

7.9 b7 b8.7 b11.2 b

Common Stock

30.8 b

Retained Earnings

(7.6 b)(4.6 b)(2.1 b)(438 m)

Total Equity

28.1 b29.9 b

Debt to Equity Ratio

1.1 x1.2 x

Debt to Assets Ratio

0.5 x0.4 x0.4 x0.4 x

Financial Leverage

2.5 x2.6 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

5.1 b5.2 b6.9 b7.7 b

Accounts Receivable

(38 m)136 m(420 m)(214 m)

Inventories

(7 m)327 m481 m(80 m)

Accounts Payable

(184 m)405 m(12 m)(44 m)

Cash From Operating Activities

6.3 b8.6 b9.1 b10.4 b

Purchases of PP&E

(693 m)(718 m)(594 m)(738 m)

Cash From Investing Activities

(8.5 b)(5.8 b)(5.5 b)(8.7 b)

Long-term Borrowings

(3.4 b)(5.6 b)(2.4 b)(3.7 b)

Dividends Paid

(1.4 b)(1.9 b)(2.4 b)(3 b)

Cash From Financing Activities

2.7 b(2.9 b)(3.1 b)(2.6 b)
USDY, 2016

EV/EBIT

15.8 x

EV/CFO

15 x

Revenue/Employee

1.2 m

Debt/Equity

1.2 x

Debt/Assets

0.4 x

Financial Leverage

2.6 x

Amgen Market Value History

Amgen Median Salaries

Source: 437 public H-1B filings from Amgen

Traffic Overview of Amgen

Amgen Online and Social Media Presence

Amgen News and Updates

Amgen chief tells Trump the biotech giant will hire 1,600 workers

Amgen Chief Executive Robert Bradway told President Trump on Tuesday that the company would soon be adding 1,600 jobs. The news of hiring by the Southern California biotech giant came as the president met with a group of pharmaceutical executives at the White House, where he told them their pric…

Amgen Tour of California announces routes for 2017 race

The Amgen Tour of California will start in Sacramento, finish in Pasadena and hit many scenic areas along the way during the seven-stage bicycle race May 14 to 20, according to route maps released Tuesday morning. Amgen also announced the routes for its four-stage Breakaway from Heart Disease wo…

Amgen Tour of California will run from Sacramento to Pasadena on May 14-20

Peter Sagan will look to add to his record 15 stage victories when he returns to the Amgen Tour of California in 2017. The seven-stage men’s race will start in Sacramento on May 14 and wrap up in Pasadena on May 20. “Racing in the Amgen Tour of California is always one of my top priorities every…

Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share

Its copycat of the top arthritis drug Enbrel was cleared by the FDA.

Amgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis

Novartis announced an FDA rejection in its earnings report.

BRIEF-Amgen and Daiichi Sankyo agree to commercialize Biosimilars in Japan

* Amgen and daiichi sankyo announce agreement to commercialize biosimilars in japan
Show more

Amgen Company Life and Culture

You may also be interested in